An antibody-lectin sandwich assay was designed to detect the aberrant glycosylation of MUC1 in sera from breast cancer patients, using an antibody to capture the protein and the lectin Con A to detect high mannose N-glycans present in MUC1 [35]. Here, MUC1 is linked to breast cancer.